This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Jun 6;373(9679):1921-2.

doi: 10.1016/S0140-6736(09)61045-X.

Preliminary HPV vaccine results for women older than 25 years

Diane M Harper¹

Affiliations

Affiliation

¹ Department of Obstetrics and Gynecology, University of Missouri-Kansas City, School of Medicine, Kansas City, MO 64139, USA. Diane.M.Harper@gmail.com <Diane.M.

PMID: 19501728
DOI: 10.1016/S0140-6736(09)61045-X

Comment

Preliminary HPV vaccine results for women older than 25 years

Diane M Harper. Lancet. 2009.

. 2009 Jun 6;373(9679):1921-2.

doi: 10.1016/S0140-6736(09)61045-X.

Author

Diane M Harper¹

Affiliation

¹ Department of Obstetrics and Gynecology, University of Missouri-Kansas City, School of Medicine, Kansas City, MO 64139, USA. Diane.M.Harper@gmail.com <Diane.M.

PMID: 19501728
DOI: 10.1016/S0140-6736(09)61045-X

No abstract available

PubMed Disclaimer

Comment on

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A. Muñoz N, et al. Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1. Lancet. 2009. PMID: 19493565 Clinical Trial.

Similar articles

Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M. Kim JJ, et al. Vaccine. 2013 Dec 30;31 Suppl 6:G65-77. doi: 10.1016/j.vaccine.2012.06.096. Vaccine. 2013. PMID: 24331822
The economic impact of HPV vaccines: not just cervical cancer.
Myers ER. Myers ER. Am J Obstet Gynecol. 2008 May;198(5):487-8. doi: 10.1016/j.ajog.2008.03.056. Am J Obstet Gynecol. 2008. PMID: 18455522 No abstract available.
Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.
Boot HJ, Wallenburg I, de Melker HE, Mangen MJ, Gerritsen AA, van der Maas NA, Berkhof J, Meijer CJ, Kimman TG. Boot HJ, et al. Vaccine. 2007 Aug 14;25(33):6245-56. doi: 10.1016/j.vaccine.2007.05.061. Epub 2007 Jun 21. Vaccine. 2007. PMID: 17630049
Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus.
Bärnighausen T, Bloom DE, Cafiero ET, O'Brien JC. Bärnighausen T, et al. Clin Microbiol Infect. 2012 Oct;18 Suppl 5:70-6. doi: 10.1111/j.1469-0691.2012.03977.x. Epub 2012 Aug 6. Clin Microbiol Infect. 2012. PMID: 22882176 Review.
Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
Poljak M. Poljak M. Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9. doi: 10.1111/j.1469-0691.2012.03946.x. Epub 2012 Aug 6. Clin Microbiol Infect. 2012. PMID: 22862799 Review.

See all similar articles

Cited by

HPV vaccines: a controversial issue?
Nicol AF, Andrade CV, Russomano FB, Rodrigues LL, Oliveira NS, Provance DW Jr. Nicol AF, et al. Braz J Med Biol Res. 2016;49(5):e5060. doi: 10.1590/1414-431X20155060. Epub 2016 Apr 8. Braz J Med Biol Res. 2016. PMID: 27074168 Free PMC article. Review.
Pattern of activation of human antigen presenting cells by genotype GII.4 norovirus virus-like particles.
Ponterio E, Petrizzo A, Di Bartolo I, Buonaguro FM, Buonaguro L, Ruggeri FM. Ponterio E, et al. J Transl Med. 2013 May 24;11:127. doi: 10.1186/1479-5876-11-127. J Transl Med. 2013. PMID: 23705987 Free PMC article.
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
Visciano ML, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L. Visciano ML, et al. J Transl Med. 2012 Jan 5;10:4. doi: 10.1186/1479-5876-10-4. J Transl Med. 2012. PMID: 22221900 Free PMC article.
Time since first sexual intercourse and the risk of cervical cancer.
Plummer M, Peto J, Franceschi S; International Collaboration of Epidemiological Studies of Cervical Cancer. Plummer M, et al. Int J Cancer. 2012 Jun 1;130(11):2638-44. doi: 10.1002/ijc.26250. Epub 2011 Aug 12. Int J Cancer. 2012. PMID: 21702036 Free PMC article.
Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the Socialist Republic of Vietnam.
Suba EJ, Raab SS. Suba EJ, et al. Diagn Cytopathol. 2012 Apr;40(4):355-66. doi: 10.1002/dc.21655. Epub 2011 Mar 10. Diagn Cytopathol. 2012. PMID: 21394935 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information